SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001655759-23-000075
Filing Date
2023-08-08
Accepted
2023-08-08 07:03:09
Documents
14
Period of Report
2023-08-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K arvn-20230808.htm   iXBRL 8-K 27150
2 EX-99.1 arvn-20230808xexx991.htm EX-99.1 107992
6 image_0.jpg GRAPHIC 32844
  Complete submission text file 0001655759-23-000075.txt   323843

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT arvn-20230808.xsd EX-101.SCH 1901
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT arvn-20230808_lab.xml EX-101.LAB 24851
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT arvn-20230808_pre.xml EX-101.PRE 13046
8 EXTRACTED XBRL INSTANCE DOCUMENT arvn-20230808_htm.xml XML 2913
Mailing Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511
Business Address 395 WINCHESTER AVE 5 SCIENCE PARK NEW HAVEN CT 06511 203-535-1456
ARVINAS, INC. (Filer) CIK: 0001655759 (see all company filings)

IRS No.: 472566120 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38672 | Film No.: 231149244
SIC: 2834 Pharmaceutical Preparations